Related Articles
FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy
Mismatched intratumoral distribution of [18F] fluorodeoxyglucose and 3'‑deoxy‑3'‑[18F] fluorothymidine in patients with lung cancer Corrigendum in /10.3892/ol.2018.8756
18F-Fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts
18F-FLT and 18F-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats
Comparison of the diagnostic performance of 18F‑fluorothymidine versus 18F‑fluorodeoxyglucose positron emission tomography on pulmonary lesions: A meta analysis